MAPK3 and systemic sclerosis: Specifically, it has been demonstrated that in SSc fibroblasts ERK1/2 activation contributes to increase the expression of fibrotic proteins, including collagen, as well as to the contraction of these cells (Bogatkevich et al., 2007; Chen et al., 2008; Lazzerini et al., 2012).